golgi developer solution Search Results


developing solution rapid golgi stain kit  (FD NeuroTechnologies)
90
FD NeuroTechnologies developing solution rapid golgi stain kit
Developing Solution Rapid Golgi Stain Kit, supplied by FD NeuroTechnologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/golgi+developer+solution/pmc03737741-49-13-14?v=FD+NeuroTechnologies
Average 90 stars, based on 1 article reviews
developing solution rapid golgi stain kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
developing solution fd neurotechnologies rapid golgi stain kit  (FD NeuroTechnologies)
90
FD NeuroTechnologies developing solution fd neurotechnologies rapid golgi stain kit
Developing Solution Fd Neurotechnologies Rapid Golgi Stain Kit, supplied by FD NeuroTechnologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/golgi+developer+solution/pmc03727626-36-15-16?v=FD+NeuroTechnologies
Average 90 stars, based on 1 article reviews
developing solution fd neurotechnologies rapid golgi stain kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
golgi developer solution  (Servicebio Inc)
86
Servicebio Inc golgi developer solution
Golgi Developer Solution, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/golgi+developer+solution/pmc12433502-179-10-13?v=Servicebio+Inc
Average 86 stars, based on 1 article reviews
golgi developer solution - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
fd rapid golgi staintm kit  (FD NeuroTechnologies)
90
FD NeuroTechnologies fd rapid golgi staintm kit
Effect of chronic oral P021 treatment on neuronal survival and dendritic spine maturation in the brain of Cdkl5 KO mice. A Number of BrdU-positive cells in the subgranular zone (SGZ) of the dentate gyrus (DG) of hippocampal sections from vehicle-treated (+ /Y n = 4, − /Y n = 3) and P021-treated (− /Y + P021 n = 4) Cdkl5 male mice. B Number of DCX-positive cells in the upper granular layer of the DG of hippocampal sections from vehicle-treated Cdkl 5 + /Y ( n = 3) and − /Y mice ( n = 3) and from P021-treated Cdkl 5 − /Y mice ( n = 4). C Examples of hippocampal sections processed for DCX immunostaining of one animal from each experimental group. D Number of NeuN-positive cells in the CA1 field of hippocampal sections from vehicle-treated Cdkl 5 + /Y and − /Y mice and from P021-treated Cdkl 5 − /Y mice as in B. E Examples of <t>Golgi-stained</t> hippocampal pyramidal neurons of one animal from each experimental group; red arrows are examples of mature mushroom-shaped spines. F Dendritic spine density in hippocampal pyramidal neurons of vehicle-treated (+ /Y n = 3, − /Y n = 3) and P021-treated (-/Y + P021 n = 3) Cdkl5 male mice. Data are expressed as number of spines per 10 µm. G Percentage of mature dendritic spines in relation to the total number of protrusions in hippocampal pyramidal neurons of Cdkl 5 + /Y and Cdkl 5 − /Y mice as in F. Values are represented as means ± SEM. ** p < 0.01, *** p < 0.001. Fisher’s LSD test after one-way ANOVA
Fd Rapid Golgi Staintm Kit, supplied by FD NeuroTechnologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/golgi+developer+solution/pmc11590213-121-14-19?v=FD+NeuroTechnologies
Average 90 stars, based on 1 article reviews
fd rapid golgi staintm kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Effect of chronic oral P021 treatment on neuronal survival and dendritic spine maturation in the brain of Cdkl5 KO mice. A Number of BrdU-positive cells in the subgranular zone (SGZ) of the dentate gyrus (DG) of hippocampal sections from vehicle-treated (+ /Y n = 4, − /Y n = 3) and P021-treated (− /Y + P021 n = 4) Cdkl5 male mice. B Number of DCX-positive cells in the upper granular layer of the DG of hippocampal sections from vehicle-treated Cdkl 5 + /Y ( n = 3) and − /Y mice ( n = 3) and from P021-treated Cdkl 5 − /Y mice ( n = 4). C Examples of hippocampal sections processed for DCX immunostaining of one animal from each experimental group. D Number of NeuN-positive cells in the CA1 field of hippocampal sections from vehicle-treated Cdkl 5 + /Y and − /Y mice and from P021-treated Cdkl 5 − /Y mice as in B. E Examples of Golgi-stained hippocampal pyramidal neurons of one animal from each experimental group; red arrows are examples of mature mushroom-shaped spines. F Dendritic spine density in hippocampal pyramidal neurons of vehicle-treated (+ /Y n = 3, − /Y n = 3) and P021-treated (-/Y + P021 n = 3) Cdkl5 male mice. Data are expressed as number of spines per 10 µm. G Percentage of mature dendritic spines in relation to the total number of protrusions in hippocampal pyramidal neurons of Cdkl 5 + /Y and Cdkl 5 − /Y mice as in F. Values are represented as means ± SEM. ** p < 0.01, *** p < 0.001. Fisher’s LSD test after one-way ANOVA

Journal: Journal of Neurodevelopmental Disorders

Article Title: Effects of a ciliary neurotrophic factor (CNTF) small-molecule peptide mimetic in an in vitro and in vivo model of CDKL5 deficiency disorder

doi: 10.1186/s11689-024-09583-4

Figure Lengend Snippet: Effect of chronic oral P021 treatment on neuronal survival and dendritic spine maturation in the brain of Cdkl5 KO mice. A Number of BrdU-positive cells in the subgranular zone (SGZ) of the dentate gyrus (DG) of hippocampal sections from vehicle-treated (+ /Y n = 4, − /Y n = 3) and P021-treated (− /Y + P021 n = 4) Cdkl5 male mice. B Number of DCX-positive cells in the upper granular layer of the DG of hippocampal sections from vehicle-treated Cdkl 5 + /Y ( n = 3) and − /Y mice ( n = 3) and from P021-treated Cdkl 5 − /Y mice ( n = 4). C Examples of hippocampal sections processed for DCX immunostaining of one animal from each experimental group. D Number of NeuN-positive cells in the CA1 field of hippocampal sections from vehicle-treated Cdkl 5 + /Y and − /Y mice and from P021-treated Cdkl 5 − /Y mice as in B. E Examples of Golgi-stained hippocampal pyramidal neurons of one animal from each experimental group; red arrows are examples of mature mushroom-shaped spines. F Dendritic spine density in hippocampal pyramidal neurons of vehicle-treated (+ /Y n = 3, − /Y n = 3) and P021-treated (-/Y + P021 n = 3) Cdkl5 male mice. Data are expressed as number of spines per 10 µm. G Percentage of mature dendritic spines in relation to the total number of protrusions in hippocampal pyramidal neurons of Cdkl 5 + /Y and Cdkl 5 − /Y mice as in F. Values are represented as means ± SEM. ** p < 0.01, *** p < 0.001. Fisher’s LSD test after one-way ANOVA

Article Snippet: After drying, sections were rinsed with distilled water, stained in the developing solution of FD Rapid Golgi StainTM Kit (FD NeuroTechnologies, Columbia, MD, USA), and coverslipped with DPX mounting medium (Sigma-Aldrich, Saint Louis, MO, USA).

Techniques: Immunostaining, Staining